Skip to main content
< Back to news
Snapshot of the "State of the art in BIO Printing” round table, chaired by IBEC Director Josep Samitier, at HEALTHIO DAY (Photo: Fundació Althaia).
 05.11.2019

IBEC presents its capabilities in 3D bioprinting at the 4th edition of INDUSTRY

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, participated in the fourth edition of INDUSTRY From Needs to Solutions, which took place from 29th to 31st October at Fira Barcelona´s Gran Via venue. The event brought together more than 150 companies in its exhibition area and 150 speakers within the framework of Barcelona Industry Week, that brought together seven major events related to digital transformation at Fira Barcelona. IoT Solutions World Congress, Blockchain Solutions World and AI & Cognitive Systems Forum were other events that added to this great summit where the achievements and innovations of disruptive technologies in the field of health became evident.

 

In its fourth edition, IN(3D)USTRY becomes INDUSTRY to include more industrial sectors, the main goal is to cover the entire value chain and provide intelligent manufacturing solutions. The institute had a stand in the exhibition area, where the representatives of the IBEC Technology Transfer Unit welcomed the interested visitors to learn more about the 3D bioprinting capabilities of IBEC.

Also, IBEC took the opportunity to show other relevant inventions in the field of diagnosis, wound care, sensory and determination of volatile gases.

“It is very important for us to be able to show at INDUSTRY the different industrial fields in which IBEC is already working, and very specifically in the field of 3D bioprinting”, said Xavier Rubies, Head of Technology Transfer at IBEC.

In addition, Javier Ramón, Principal Investigator at IBEC, participated in the round table organized by HEALTHIO on “State of the art in BIO Printing” chaired by Josep Samitier, IBEC Director. Javier Ramón gave a talk about the work they are doing in their 3D bioprinting laboratory and the organ-on-a-chip. The other participants in the round table were Axel Guenther, professor at the University of Toronto at the Faculty of Applied Sciences and Engineering, and Tamer Mohamed, director of the company Aspect Biosystems. The session was dedicated to how bioprinting can contribute to the health field.

On the 31st, IBEC organized a round table “3D Printing in healthcare” where Tamer Mohamed gave a talk on how to go step forward, from the research that is carried out in the laboratory to the market. He also presented the latest trends in 3D bioprinting and its application to health. The company Aspect Biosystems focuses on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to create physiologically and commercially relevant tissues. These tissues are used to advance and accelerate drug discovery and development, and enable the creation of cutting-edge tissue therapies of the future.

► More information: IBEC website [+]